Argent Biopharma Statistics
Argent Biopharma (H5O0) Stock Statistics & Valuation Metrics
Total Valuation
Argent Biopharma has a market cap or net worth of EUR 1.52M. The enterprise value is EUR 12.72M.
- Market Cap
- EUR 1.52M
- Enterprise Value
- EUR 12.72M
Share Statistics
Argent Biopharma has 117,859,580 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 117,859,580
- Owned by Insiders
- 5.94%
- Owned by Institutions
- ―
Financial Efficiency
Argent Biopharma’s return on equity (ROE) is 0.82 and return on invested capital (ROIC) is -5166.99%.
- Return on Equity (ROE)
- 0.82
- Return on Assets (ROA)
- -5.95
- Return on Invested Capital (ROIC)
- -5166.99%
- Return on Capital Employed (ROCE)
- 1.02
- Revenue Per Employee
- 32.24K
- Profits Per Employee
- -1.54M
- Employee Count
- 5
- Asset Turnover
- 0.12
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Argent Biopharma is -0.20. Argent Biopharma’s PEG ratio is -0.00.
- PE Ratio
- -0.20
- PS Ratio
- 15.36
- PB Ratio
- -0.22
- Price to FCF
- -0.46
- Price to Operating Cash Flow
- -0.38
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Argent Biopharma had revenue of 161.19K and earned -7.71M in profits. Earnings per share was -0.09.
- Revenue
- 161.19K
- Gross Profit
- -204.21K
- Operating Income
- -7.39M
- Pretax Income
- -7.71M
- Net Income
- -7.71M
- EBITDA
- -7.23M
- Earnings Per Share (EPS)
- -0.09
Cash Flow
In the last 12 months, operating cash flow was -5.33M and capital expenditures -2,421, giving a free cash flow of -5.33M billion.
- Operating Cash Flow
- -5.33M
- Free Cash Flow
- -5.33M
- Free Cash Flow per Share
- -0.05
Dividends & Yields
Argent Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -215.38%
- Earnings Yield
- -449.59%
Stock Price Statistics
- Beta
- -2.72
- 52-Week Price Change
- -70.59%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 47.86
- Average Volume (3m)
- 3,715
Important Dates
Argent Biopharma upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Argent Biopharma as a current ratio of 0.05, with Debt / Equity ratio of -101.51%
- Current Ratio
- 0.05
- Quick Ratio
- 0.05
- Debt to Market Cap
- 3.05
- Net Debt to EBITDA
- -1.31
- Interest Coverage Ratio
- -219.33
Taxes
In the past 12 months, Argent Biopharma has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Argent Biopharma EV to EBITDA ratio is -1.38, with an EV/FCF ratio of -2.24.
- EV to Sales
- 73.96
- EV to EBITDA
- -1.38
- EV to Free Cash Flow
- -2.24
- EV to Operating Cash Flow
- -2.24
Balance Sheet
Argent Biopharma has EUR 141.46K in cash and marketable securities with EUR 9.59M in debt, giving a net cash position of -EUR 9.45M billion.
- Cash & Marketable Securities
- EUR 141.46K
- Total Debt
- EUR 9.59M
- Net Cash
- -EUR 9.45M
- Net Cash Per Share
- -EUR 0.08
- Tangible Book Value Per Share
- -EUR 0.10
Margins
Gross margin is -126.69%, with operating margin of -4586.90%, and net profit margin of -5693.88%.
- Gross Margin
- -126.69%
- Operating Margin
- -4586.90%
- Pretax Margin
- -4783.36%
- Net Profit Margin
- -5693.88%
- EBITDA Margin
- -5365.48%
- EBIT Margin
- -5516.60%
Analyst Forecast
The average price target for Argent Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.33%
- EPS Growth Forecast
- 76.52%
Scores
- Smart Score
- 7
- AI Score
- ―

